[Immunological imbalance in the newborn infant and its correction in a system to prevent neonatal morbidity and infant mortality].
Immunological changes were examined in neonates having a different clinical status and varying effects of immunomodulation. The paper shows it expedient to use intravenous immunoglobulin as part of a package of measures to nurse premature neonates. A method for evaluating the responsiveness of immunocytes in the newborn has been developed, which is based on the determination of the equilibrium between activation-induced T-cell proliferation and apoptosis.
I N
IN
Blokhina
O V
OV
Milovidova
V Iu
VIu
Talaev
A V
AV
Chudner
D000917:Antibody Formation; D006801:Humans; D007154:Immune System Diseases / Q000150:complications / Q000276:immunology / Q000628:therapy*; D007111:Immunity, Cellular; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D007226:Infant Mortality; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000276:immunology
D016756:Immunoglobulins, Intravenous
Immunologicheskiĭ disbalans novorozhdennogo i ego korrektsiia v sisteme preduprezhdeniia neonatal'noĭ zabolevaemosti i mladencheskoĭ smertnosti.